Peripheral Blood Stem Cell TransplantationTransplantation, AutologousBone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousTransplantation ConditioningGraft vs Host DiseaseHematopoietic Stem Cell MobilizationHematologic NeoplasmsCombined Modality TherapyGranulocyte Colony-Stimulating FactorMelphalanAntigens, CD34BusulfanCyclophosphamideLeukapheresisStem Cell TransplantationGraft SurvivalBlood Component RemovalHematopoietic Stem CellsMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeWhole-Body IrradiationBone MarrowRecurrenceRemission InductionLymphoma, Non-HodgkinTransplantation ChimeraStem CellsMyeloablative AgonistsTissue DonorsLeukemiaEtoposideBone Marrow CellsHistocompatibility TestingHematopoiesisAnemia, AplasticThiotepaHistocompatibilityAntineoplastic Agents, AlkylatingCarmustineCord Blood Stem Cell TransplantationCytarabineSalvage TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteDisease-Free SurvivalRetrospective StudiesTransplantation, IsogeneicTime FactorsSurvival AnalysisCytophagocytosisSurvival RateImmunosuppressive AgentsVincristineGraft vs Leukemia EffectIfosfamideHodgkin DiseaseLymphocyte DepletionBone Marrow PurgingAmyloidosisInfectionGraft vs Tumor EffectPrecursor Cell Lymphoblastic Leukemia-LymphomaNeoplasmsLeukocyte TransfusionMyelodysplastic SyndromesCytomegalovirus InfectionsT-LymphocytesFollow-Up StudiesFatal OutcomeLiver TransplantationAcute DiseaseImmunosuppressionPlatelet CountLymphocyte TransfusionHematologic DiseasesHLA AntigensBlood Cell CountCyclosporinePrednisoneLymphomaDoxorubicinLymphoma, T-CellRecombinant ProteinsNuclear FamilyProspective StudiesTransplantation ImmunologyHepatic Veno-Occlusive DiseaseLeukemia, MyeloidImmunophenotypingBlood CellsVidarabinePOEMS SyndromeRadiation ChimeraAntineoplastic AgentsCarboplatinMice, Inbred C57BLDexamethasone